18.12.2012 Views

Myeloid Leukemia

Myeloid Leukemia

Myeloid Leukemia

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

96 Branford and Hughes<br />

kinase domain. The PCR product is directly sequenced in the forward and<br />

reverse directions using dye terminator chemistry and a 3700 DNA Sequencer<br />

(Applied Biosystems, Foster City, CA, USA) (16,28). Mutation Surveyor software<br />

(SoftGenetics, LLC, State College, PA) is used to analyze the sequence.<br />

RNA extracted from peripheral blood or bone marrow is suitable for analysis.<br />

The technique is also applicable for imatinib-treated patients with Philadelphia<br />

chromosome-positive acute lymphoblastic leukemia (ALL). These patients<br />

may have a BCR-ABL transcript that is the same as that present in most patients<br />

with CML (b2a2 or b3a2 BCR-ABL), or the transcript may involve the fusion<br />

of BCR exon 1 to ABL exon 2 (e1a2 BCR-ABL). For patients with the e1a2<br />

transcript, an alternate 5� PCR primer is required.<br />

The ability to detect mutations is very dependent on the quality of the RNA,<br />

which is assessed prior to mutation analysis by measurement of the level of<br />

normal BCR mRNA using real-time quantitative PCR (29). A cutoff level based<br />

on the number of detectable BCR transcripts in the sample was established as<br />

an indicator of degraded RNA. Samples with BCR levels below the cutoff are<br />

not assessed for mutations. This technique permits the detection of single or<br />

multiple mutations in patients with disease status ranging from a complete<br />

cytogenetic response (Philadelphia chromosome negative) to overt relapse, at<br />

a sensitivity of 20%. To date, we have detected 24 different point mutations,<br />

spanning the entire kinase domain and ranging from amino acid 244 to 486<br />

(GenBank accession number M14752). Identification of these mutations is of<br />

clinical significance, because virtually all CML patients with detectable mutations<br />

acquire resistance to imatinib (16,22).<br />

2. Materials<br />

2.1. Semi-Nested PCR Reaction<br />

1. Sterile 0.2-mL capped PCR tubes (Interpath Services).<br />

2. Sterile 1.5-mL capped PCR tubes (Interpath Services).<br />

3. 500-µL single-use lots of autoclaved MiliQ water. Store at room temperature in<br />

1.5-mL tubes.<br />

4. PCR primers. All primers are ordered as a 50 µM solution and stored in 30-µL<br />

lots at 20°C. Primers were designed using Primer Express software (Applied<br />

Biosystems).<br />

5. 15 mM stock of dNTPs (Amersham Biosciences). Store at –20°C in 100-µL lots.<br />

6. 25 mM MgCl 2 (Applied Biosystems). Store at –20°C.<br />

7. Expand Long Template PCR System (Roche). Store at –20°C.<br />

8. PCR cabinet with ultraviolet light.<br />

9. UltraClean PCR Clean-up DNA purification kit (Mo Bio Laboratories). Store at<br />

room temperature.<br />

10. Agarose, molecular-biology grade (Progen). Store at room temperature.<br />

11. SPP1/EcoR1 DNA molecular-weight marker (Geneworks). Store at –20°C.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!